Cargando…

Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials

To assess the efficacy and safety of interleukin (IL)-17A inhibitors in patients with ankylosing spondylitis (AS). PubMed, EMBASE, and Web of Science were searched up to 5 February 2020 for randomized controlled trials (RCTs) that assessed the efficacy and safety of IL-17A inhibitors in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng, Zhang, Shuo, Hu, Binwu, Liu, Weijian, Lv, Xiao, Chen, Songfeng, Shao, Zengwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289786/ https://www.ncbi.nlm.nih.gov/pubmed/33432451 http://dx.doi.org/10.1007/s10067-020-05545-y

Ejemplares similares

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages
por: Zhang, Shuo, et al.
Publicado: (2022)

The Prognostic Role of Ribosomal Protein S6 Kinase 1 Pathway in Patients With Solid Tumors: A Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2019)

Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis
por: Yin, Yufeng, et al.
Publicado: (2020)

Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021)

Selenium Attenuates TBHP-Induced Apoptosis of Nucleus Pulposus Cells by Suppressing Mitochondrial Fission through Activating Nuclear Factor Erythroid 2-Related Factor 2
por: Wang, Peng, et al.
Publicado: (2022)

Effectiveness of interleukin-17A inhibitors in patients with ankylosing spondylitis: A protocol for systematic review and meta-analysis
por: Yan, Mingguang, et al.
Publicado: (2022)

Efficacy and safety of adalimumab in ankylosing spondylitis
por: Mounach, Aziza, et al.
Publicado: (2014)

Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis
por: Hu, Binwu, et al.
Publicado: (2018)

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis
por: Hu, Binwu, et al.
Publicado: (2018)

Efficacy and safety of IL inhibitors, TNF-α inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis
por: Tian, Cong, et al.
Publicado: (2023)

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
por: Senabre-Gallego, José Miguel, et al.
Publicado: (2013)

Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
por: Elalouf, Ofir, et al.
Publicado: (2015)

Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials
por: Long, Zhiyong, et al.
Publicado: (2023)

Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis
por: Hu, Binwu, et al.
Publicado: (2018)

Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis
por: He, Tao, et al.
Publicado: (2017)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
por: Girbash, Ehab F., et al.
Publicado: (2023)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

The efficacy and safety of Health Qigong for ankylosing spondylitis: Protocol for a systematic review and meta-analysis
por: Liu, Biyuan, et al.
Publicado: (2020)

Efficacy and Safety of Sinomenine Preparation for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Trials
por: Lin, Shan-Shan, et al.
Publicado: (2020)

Inhibiting Heat Shock Protein 90 Protects Nucleus Pulposus-Derived Stem/Progenitor Cells From Compression-Induced Necroptosis and Apoptosis
por: Hu, Binwu, et al.
Publicado: (2020)

HSP70 attenuates compression-induced apoptosis of nucleus pulposus cells by suppressing mitochondrial fission via upregulating the expression of SIRT3
por: Hu, Binwu, et al.
Publicado: (2022)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Efficacy and safety of TNF-α inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
por: Lee, Young Ho
Publicado: (2022)

Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)
por: Ajibade, Adeola, et al.
Publicado: (2023)

The Efficacy and Safety of Simple-Needling Therapy for Treating Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Xuan, Yichen, et al.
Publicado: (2020)

Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs
por: Zhou, Yu, et al.
Publicado: (2020)

Efficacy and safety of warm acupuncture in the treatment of ankylosing spondylitis: A protocol for systematic review and meta-analysis
por: Dang, Sha, et al.
Publicado: (2021)

Musculoskeletal ultrasound for ankylosing spondylitis: A systematic review and meta-analysis
por: Zhu, Lin, et al.
Publicado: (2021)

The efficacy and safety of Yijinjing exercise in the adjuvant treatment of ankylosing spondylitis: A protocol of randomized controlled trial
por: Chen, Yuxuan, et al.
Publicado: (2021)

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015)

Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis
por: Betts, Keith A., et al.
Publicado: (2016)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Ankylosing Spondylitis and the Risk of Lung Cancer: A Meta-Analysis and Mendelian Randomization
por: Ao, Yiyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pagma8feli90qfch054eokfrvs